Health Care & Life Sciences » Biotechnology | OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
316,194.00
231,966.00
157,279.00
184,573.00
103,091.00
Total Accounts Receivable
23.00
7,123.00
70,699.00
2,515.00
405.00
Other Current Assets
2,527.00
1,721.00
3,277.00
2,495.00
1,709.00
Total Current Assets
318,744.00
240,810.00
231,255.00
189,583.00
105,205.00
Net Property, Plant & Equipment
4,641.00
5,104.00
4,825.00
4,471.00
3,275.00
Other Assets
10,300.00
1,928.00
1,807.00
1,428.00
1,842.00
Total Assets
333,685.00
247,842.00
237,887.00
195,482.00
110,322.00
Accounts Payable
5,706.00
4,428.00
6,660.00
4,890.00
2,565.00
Income Tax Payable
10,758.00
-
-
-
-
Other Current Liabilities
45,553.00
34,118.00
45,981.00
50,963.00
90,567.00
Total Current Liabilities
62,017.00
38,546.00
52,641.00
55,853.00
93,132.00
Other Liabilities
153,546.00
132,929.00
181,695.00
162,657.00
65,793.00
Total Liabilities
215,563.00
171,475.00
234,336.00
218,510.00
158,925.00
Common Equity (Total)
118,122.00
76,367.00
3,551.00
23,028.00
48,603.00
Total Shareholders' Equity
118,122.00
76,367.00
3,551.00
23,028.00
48,603.00
Total Equity
118,122.00
76,367.00
3,551.00
23,028.00
48,603.00
Liabilities & Shareholders' Equity
333,685.00
247,842.00
237,887.00
195,482.00
110,322.00

About OncoMed Pharmaceuticals

View Profile
Address
800 Chesapeake Drive
Redwood City California 94063
United States
Employees -
Website http://www.oncomed.com
Updated 09/14/2018
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.